Axiom Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-225
| Closed | -$25K | – | 155 |
|
|
2021
Q4 | $25K | Buy |
+225
| New | +$25K | 0.02% | 130 |
|
|
2021
Q3 | – | Sell |
-1,500
| Closed | -$203K | – | 170 |
|
|
2021
Q2 | $203K | Sell |
1,500
-1,257
| -46% | -$170K | 0.16% | 127 |
|
|
2021
Q1 | $374K | Buy |
2,757
+2,616
| +1,855% | +$355K | 0.3% | 78 |
|
|
2020
Q4 | $388 | Sell |
141
-2,612
| -95% | -$7.19K | 0.35% | 65 |
|
|
2020
Q3 | $307K | Buy |
2,753
+3
| +0.1% | +$335 | 0.35% | 75 |
|
|
2020
Q2 | $308K | Buy |
+2,750
| New | +$308K | 0.41% | 66 |
|